𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Quantitative nuclear morphology in the diagnosis of ovarian tumors of low malignant potential (borderline)

✍ Scribed by Dymitr Komitowski; Catherine Janson; Josef Szamaborski; Bernard Czernobilsky


Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
625 KB
Volume
64
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Aberrant promoter methylation of multipl
✍ Andrew Wiley; Dionyssios Katsaros; Haigang Chen; Irene A. Rigault de la Longrais πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 217 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Methylation‐mediated suppression of detoxification, DNA repair, and tumor suppressor genes has been implicated in cancer development and progression. Studies also have indicated that concordant methylation of multiple genes (methylator phenotypes), rather than a single g

The role of DNA flow cytometry in border
✍ Chyong-Huey Lai; Swei Hsueh; Ting-Chang Chang; Chih-Jen Tseng; Kuan-Gen Huang; H πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 923 KB

## BACKGROUND. The role of flow cytometric DNA analysis in predicting prognosis of patients with borderline malignant ovarian tumors has been controversial. ## METHODS. Fifty cases of patients with borderline malignant ovarian tumors were analyzed by histology and by flow cytometry on paraffin

A review of p53 expression and mutation
✍ Leanne M. Kmet; Linda S. Cook; Anthony M. Magliocco πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 223 KB

## Abstract ## BACKGROUND In the current study, the authors present pooled data from studies that investigated p53 protein expression and/or mutation in human epithelial ovarian tumors. ## METHODS The English literature in the MEDLINE, PubMed, and Ingenta databases was searched to the end of the

Ovarian papillary serous tumors of low m
✍ Alexander W. Kennedy; William R. Hart πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 900 KB

## Background: The clinical outcome of patients with ovarian serous tumors of low malignant potential (lmp) remains controversial, especially for those with extraovarian disease. we retrospectively reviewed our experience to study this question further, to assess the safety of conservative manageme